Celebrating the great minds that bring us innovation in small molecules, biopharmaceuticals, and advanced medicine.
Fujifilm Toyama's influenza treatment passes COVID-19 trial.
Exploring a new approach to treating IBS pain.
In what ways can the microbiome interact with oral medicines?
Robert W. Lee
Why drug developers should take a fresh look at long-acting dosage forms.
When it comes to using AI in drug development, companies need to consider how they create and protect their intellectual property.
Can we trust the integrity of clinical trials?
One analytical technique that is seeing increasing popularity, in part due to its precision and reproducibility, is capillary electrophoresis.
The drug development system is broken; the COVID-19 pandemic is an opportunity to take a bold step towards accessible and affordable therapies.
Acetaminophen derivatives could offer patients a safer alternative to common pain management treatments.
How can companies be encouraged to develop treatments for the growing number of patients living with CNS disorders?
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.